Clinical Trial Update: Clinical Trial of NAC in Asthma [Phase 4]

View source ↗

Summary

Phase 4 clinical trial of N-acetylcysteine (NAC) in asthma was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: University of California, San Francisco | Conditions: Asthma | Phase 4 | Status: TERMINATED | Results posted: 2019-08-20